Resolutions at Getinge’s Annual General Meeting

At the Annual General Meeting of Getinge AB held on 25 March 2015, the following
was resolved.

Election of Board of Directors

Carl Bennet (Chairman), Johan Bygge, Cecilia Daun Wennborg, Carola Lemne, Malin
Persson, Johan Stern and Maths Wahlström were re-elected as members of the
Board. Alex Myers was elected new member of the Board

Fees to the Board of Directors

It was resolved that remuneration to the Board of Directors shall, unchanged,
amount to a total of SEK 4,400,000 excluding remuneration for Committee work, of
which SEK 1,100,000 to the Chairman and SEK 550,000 to each of the other Board
members elected by the Meeting who are not employees of Getinge Group. In
addition hereto, the Meeting resolved that work in the Audit Committee shall,
unchanged, be compensated with SEK 240,000 to the Chairman and SEK 120,000 to
each of the other members, while work in the Remuneration Committee work shall
be, unchanged, compensated with SEK 125,000 to the Chairman and SEK 92,000 to
each of the other members.

Dividend

In accordance with the proposal of the Board of Directors and the CEO, the
Annual General Meeting resolved to declare a dividend of SEK 2.80 per share.
Tuesday 27 March 2015 was determined as record date for dividend.

Guidelines for Remuneration to Senior Executives

The Annual General Meeting approved the proposal of the Board regarding
guidelines for remuneration to senior executives, which principally involve the
following. Remuneration and other terms and conditions of employment for senior
executives shall be based on market conditions and be competitive in all markets
where Getinge operates, to ensure that competent and skilful employees can be
attracted, motivated and retained. The total remuneration to senior executives
shall comprise basic salary, variable remuneration, pensions and other benefits.
The variable remuneration shall be limited and connected to predetermined and
measurable criteria elaborated with the purpose to promote the long-term added
value of the company. The Board shall retain the right to deviate from the
guidelines if motivated by particular reasons on an individual basis.

For further information, please contact:

Alex Myers                                             Ulf Grunander

CEO, Getinge Group                                CFO, Getinge Group

Tel: +46 10 335 00 00                              Tel: +46 10 335 55 80

E-mail: alex.myers@getinge.com             E-mail: ulf.grunander@getinge.com

About Getinge Group

The Getinge Group is a global leading medical technology company that operates
in the areas of surgery, intensive care, infection control, care ergonomics and
wound care. The Group is divided into three business areas: Extended Care,
Infection Control and Medical Systems, and operates under the brands
ArjoHuntleigh, Getinge and Maquet.

Getinge AB discloses the information herein in accordance with the Swedish
Securities Market Act and/or the Financial Instruments Trading Act. The
information was submitted for publication on 25 March 2015 at 18.00 CET.